Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00182286
Other study ID # RC 1030106
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated September 13, 2005
Start date September 1999
Est. completion date July 2001

Study information

Verified date August 2005
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Observational

Clinical Trial Summary

This project was conducted with patients at a multi-disciplinary, multi-specialty health services organization serving 44,000 rostered patients in Northern Ontario. It investigated continuity of care for patients with diabetes in the areas of barriers and potential solutions to, and correlates of continuity; and variability in costs associated with continuity of care and patient outcomes.


Description:

Continuity of care is a concept that has been garnering increased attention in the last few years. There have been multiple methods proposed by researchers for measuring continuity of care, most of which are based on proportions or ratios of visits to the same health care provider or centre. While a consistent method for measuring continuity of care is lacking, increased continuity of care using various definitions and measurement tools has been related to better well being, lower health care costs, better glucose control, and higher satisfaction but has also not been found to improve health outcomes in other scenarios. Whether a patient is better served by high sequential access to one provider or any provider within the same system or management team is controversial. Finally, patients’ perceptions of continuity of care have not been generally evaluated or correlated with current measurement methods. This project was conducted with patients at the Group Health Centre in Sault Ste Marie, Ontario, a multi-disciplinary, multi-specialty health services organization serving 44,000 rostered patients


Recruitment information / eligibility

Status Completed
Enrollment 342
Est. completion date July 2001
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults (>18 years)

- Diagnosis of diabetes mellitus (according to the definition used in 1999 by the Canadian Diabetes Association

Exclusion Criteria:

- Gestational diabetes

- Could not communicate in English

- Life expectancy or residency expectancy in Sault Ste Marie of less than three years

Study Design

Observational Model: Defined Population, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Behavioral:
Assessment of continuity of care from the patient perspective

Relationship between continuity of care, patient outcomes, and costs


Locations

Country Name City State
Canada Group Health Centre Sault Ste. Marie Ontario

Sponsors (5)

Lead Sponsor Collaborator
Hamilton Health Sciences Corporation Canadian Health Services Research Foundation, Group Health Centre, Group Health Centre, Sault Ste Marie, ON, Ontario Ministry of Health and Long Term Care

Country where clinical trial is conducted

Canada, 

References & Publications (2)

Dolovich LR, Nair KM, Ciliska DK, Lee HN, Birch S, Gafni A, Hunt DL. The Diabetes Continuity of Care Scale: the development and initial evaluation of a questionnaire that measures continuity of care from the patient perspective. Health Soc Care Community. — View Citation

Nair KM, Dolovich LR, Ciliska DK, Lee HN. The perception of continuity of care from the perspective of patients with diabetes. Fam Med. 2005 Feb;37(2):118-24. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A